Picture of Genmab A/S logo

GMAB Genmab A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

Genmab's blood cancer drug fails main goal in late-stage study

Jan 16 (Reuters) - Danish drugmaker Genmab GMAB.CO said on Friday that its experimental drug for a type of blood cancer failed to meet the main goal in a late-stage study.

 (Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Alan Barona)

 ((Padmanabhan.Ananthan@thomsonreuters.com;))

Recent news on Genmab A/S

See all news